Immune-mediated Neuropathy with Epstein-Barr virus-positive T-cell Lymphoproliferative Disease

被引:0
|
作者
Hattori, Takaaki [1 ]
Arai, Ayako [2 ]
Yokota, Takanori [1 ]
Imadome, Ken-Ichi [3 ]
Tomimitsu, Hiroyuki [1 ]
Miura, Osamu [2 ]
Mizusawa, Hidehiro [1 ]
机构
[1] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Tokyo, Japan
[2] Tokyo Med & Dent Univ, Dept Hematol, Tokyo, Japan
[3] Natl Res Inst Child Hlth & Dev, Dept Infect Dis, Tokyo, Japan
基金
日本学术振兴会;
关键词
neuropathy; EBV-T/NK-LPD; CAEBV; immune-mediated; Guillain-Barre syndrome; INFECTION; TRANSPLANTATION; GUIDELINES;
D O I
10.2169/internalmedicine.54.3173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 47-year-old man with Epstein-Barr virus (EBV)-positive T/NK-cell lymphoproliferative disease (EBVT/NK-LPD) developed acute-onset weakness. A nerve conduction study showed a conduction block in both the proximal and most distal segments. Although the patient's neuropathy transiently responded to intravenous immunoglobulin, it was progressive for at least 25 days until the start of prednisolone (PSL) administration, after which it remarkably improved. The neuropathy further improved after allogeneic bone marrow transplantation (BMT). The present patient's clinical course is not consistent with that of typical Guillain-Barre syndrome. This case suggests that EBV-T/NK-LPD can cause progressive immune-mediated neuropathy as a result of chronic EBV antigen presentation and can be treated with PSL and BMT.
引用
收藏
页码:69 / 73
页数:5
相关论文
共 50 条
  • [1] Adult systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease: A case report
    Wang, Youping
    Liu, Xinyue
    Chen, Yan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (03) : 1025 - 1028
  • [2] Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
    Wongwiwat, Wiyada
    Fournier, Benjamin
    Bassano, Irene
    Bayoumy, Amr
    Elgueta Karstegl, Claudio
    Styles, Christine
    Bridges, Ray
    Lenoir, Christelle
    BoutBoul, David
    Moshous, Despina
    Neven, Benedicte
    Kanda, Teru
    Morgan, Rhys G.
    White, Robert E.
    Latour, Sylvain
    Farrell, Paul J.
    JOURNAL OF VIROLOGY, 2022, 96 (12)
  • [3] Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders
    Cai, Qingqing
    Chen, Kailin
    Young, Ken H.
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2015, 47 : e133 - e133
  • [4] Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood: Report of a case with review of the literature
    Yoshii, Miyuki
    Ishida, Mitsuaki
    Hodohara, Keiko
    Okuno, Hiroko
    Nakanishi, Ryota
    Yoshida, Takashi
    Okabe, Hidetoshi
    ONCOLOGY LETTERS, 2012, 4 (03) : 381 - 384
  • [5] Systemic Epstein-Barr Virus-positive T-Cell Lymphoproliferative Disease of Childhood With Good Response to Steroid Therapy
    Kim, Do-Hoon
    Kim, Myungshin
    Kim, Yonggoo
    Han, Kyungja
    Han, Eunhee
    Lee, Jae Wook
    Chung, Nack-Gyun
    Cho, Bin
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (08) : E497 - E500
  • [6] Aberrant expression of NK cell receptors in Epstein-Barr virus-positive γδ T-cell lymphoproliferative disorders
    Zhang, Yu
    Ohyashiki, Junko H.
    Shimizu, Norio
    Ohyashiki, Kazuma
    HEMATOLOGY, 2010, 15 (01) : 43 - 47
  • [7] CYTOTOXIC T-CELL CONTROL OF EPSTEIN-BARR VIRUS-POSITIVE MALIGNANCIES
    RICKINSON, A
    BROOKS, J
    LEE, S
    KURILLA, M
    ROWE, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 41 - 41
  • [8] Systemic Epstein-Barr Virus-Positive T-cell Lymphoma of Childhood
    Wu, Qiong
    Ren, Faliang
    Elston, Dirk M.
    CUTIS, 2019, 104 (05): : 297 - 300
  • [9] Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma
    Cai, Qingqing
    Cai, Jun
    Fang, Yu
    Young, Ken H.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [10] Adoptive T-cell therapy for Epstein-Barr virus-positive Hodgkin's disease
    Huls, MH
    Rooney, CM
    Heslop, HE
    ACTA HAEMATOLOGICA, 2003, 110 (2-3) : 149 - 153